Russell Investments Group Ltd. Boosts Stock Holdings in Agilent Technologies, Inc. $A

Russell Investments Group Ltd. lifted its position in Agilent Technologies, Inc. (NYSE:A) by 11.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 749,294 shares of the medical research company’s stock after purchasing an additional 75,811 shares during the period. Russell Investments Group Ltd.’s holdings in Agilent Technologies were worth $99,529,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Fiduciary Trust Co grew its position in Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares during the period. Sapient Capital LLC raised its position in shares of Agilent Technologies by 4.2% in the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after acquiring an additional 85 shares during the period. Plan A Wealth LLC raised its position in shares of Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after acquiring an additional 92 shares during the period. IHT Wealth Management LLC boosted its stake in shares of Agilent Technologies by 4.9% during the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock worth $278,000 after acquiring an additional 96 shares in the last quarter. Finally, KPP Advisory Services LLC boosted its stake in shares of Agilent Technologies by 2.4% during the 2nd quarter. KPP Advisory Services LLC now owns 4,382 shares of the medical research company’s stock worth $582,000 after acquiring an additional 103 shares in the last quarter.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $148.55 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The firm has a market capitalization of $41.95 billion, a PE ratio of 29.83, a P/E/G ratio of 2.63 and a beta of 1.25. The business’s 50 day moving average price is $135.38 and its 200-day moving average price is $125.56.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm’s revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were issued a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Analysts Set New Price Targets

A has been the topic of a number of analyst reports. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price on the stock. Jefferies Financial Group began coverage on Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price target for the company. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Piper Sandler began coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective on the stock. Finally, Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.